Measuring cancer cell state can reveal drug susceptibility
Study results also show that pancreatic tumor cells can be forced into a more susceptible state by changing their environment.
Study results also show that pancreatic tumor cells can be forced into a more susceptible state by changing their environment.
A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
Exploring diversity among bacterial immune systems, McGovern Institute scientists uncovere a programmable system for precisely targeting and modifying RNA.
Researchers find RNA-guided enzymes are more diverse and widespread than previously believed.
Made of components found in the human body, the programmable system is a step toward safer, targeted delivery of gene editing and other molecular therapeutics.
Four times faster than conventional PCR methods, new RADICA approach is highly specific, sensitive, and resistant to inhibitors.
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
Expanding tissue samples before sequencing allows researchers to pinpoint locations of RNA molecules.
Two MIT faculty members earn funding from the G. Harold and Leila Y. Mathers Foundation.
Research suggests the products of transcription — RNA molecules — regulate their own production through a feedback loop.
Curiosity-driven basic science in the 1970s laid the groundwork for today’s leading vaccines against the novel coronavirus.
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Tiny microRNAs help destroy unwanted messenger RNAs in cells. New research finds how the body keeps them in check.
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.